← Back to Search

Behavioral Intervention

Exercise Program for Muscle Loss

N/A
Waitlist Available
Led By Brenda Goodrich, DO
Research Sponsored by Geisinger Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age greater than or equal to 65 years
A score greater than 4 on the Strength, Assistance with walking, Rising from a chair, Climbing stairs and Falls questionnaire (SARC-F)
Must not have
An inability to perform an exercise program independently
Diagnosis of mild cognitive impairment, neurological disorders, uncontrolled metabolic disease, history of pacemaker or cardiovascular disease or high blood pressure not controlled with medication
Timeline
Screening 3 weeks
Treatment Varies
Follow Up prior to the start of the intervention (week 1), mid-point of the intervention (week 4), following the completion of the intervention (week 8)
Awards & highlights

Summary

This trial aims to see if older adults with muscle loss will feel better and perform better after an 8-week exercise program compared to a group that does not exercise. They will also ask the participants about

Who is the study for?
This trial is for community-dwelling older adults aged 65 or above with probable sarcopenia, as indicated by specific scores on the SARC-F questionnaire and hand grip strength tests. Participants must be able to consent and be patients at the Geisinger 65Forward Scranton clinic.
What is being tested?
The study is testing an 8-week multicomponent exercise training program's effectiveness in improving physical performance and patient-reported outcomes for older adults with muscle loss, compared to a control group not receiving the intervention.
What are the potential side effects?
While not explicitly listed, potential side effects may include typical exercise-related risks such as muscle soreness, fatigue, joint pain or injury. However, these are generally mild and manageable.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.
Select...
I scored over 4 on a physical ability questionnaire.
Select...
My hand grip strength is below the required level for my gender.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot do an exercise program on my own.
Select...
I have mild cognitive issues or certain uncontrolled health conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~prior to the start of the intervention (week 1), mid-point of the intervention (week 4), following the completion of the intervention (week 8)
This trial's timeline: 3 weeks for screening, Varies for treatment, and prior to the start of the intervention (week 1), mid-point of the intervention (week 4), following the completion of the intervention (week 8) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Falls Efficacy Scale-International (FES-I) score
Sarcopenia Quality of Life (SarQoL) score
Short Physical Performance Battery (SPPB) composite score
Secondary study objectives
Hand Grip Strength score
Other study objectives
Qualitative Data from semi-structured interviews

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Multicomponent Training InterventionExperimental Treatment1 Intervention
Subjects in the intervention group will attend two standardized group-based sixty-minute sessions per week in the outpatient medical center and will be asked not to change their current physical activity regimen during the 8-week duration of the study.
Group II: Control GroupActive Control1 Intervention
Subjects in the control group will be asked to not change their current level of physical activity during the 8-week duration of the study.

Find a Location

Who is running the clinical trial?

Geisinger ClinicLead Sponsor
153 Previous Clinical Trials
1,974,131 Total Patients Enrolled
Brenda Goodrich, DOPrincipal InvestigatorGeisinger Clinic
Shala Davis, PhDStudy ChairEast Stroudsburg University
~17 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top